24/7 Market News Snapshot 25 June, 2025 – Portage Biotech Inc. Common Stock (NASDAQ:PRTG)

June 25, 2025

DENVER, Colo., 25 June, 2025 (www.247marketnews.com) – (NASDAQ:PRTG) are discussed in this article.
Portage Biotech Inc. (NASDAQ:PRTG) is experiencing a significant surge in pre-market trading, currently priced at $7.249, reflecting a remarkable increase of 34.74% from its previous close at $5.380. This uptick, accompanied by a trading volume of 1.3 million shares, indicates robust investor enthusiasm and a positive market sentiment surrounding the company. Such momentum aligns with ongoing advancements in the biotech sector, suggesting potential for further growth in the near future.

In parallel to this market activity, Portage Biotech announced that it has received formal confirmation from The Nasdaq Stock Market LLC regarding its compliance with all necessary requirements for continued listing on The Nasdaq Capital Market. This milestone underscores Portage’s commitment to its innovative immuno-oncology pipeline, which is focused on developing novel biologics designed to enhance the immune response against cancer.

The company’s portfolio includes groundbreaking therapeutic approaches that aim to provide new treatment options for patients battling various types of cancer. With a steadfast focus on research and development, Portage is strategically positioned to make significant contributions to the evolving immunotherapy landscape.

In a statement from the company’s leadership, they expressed enthusiasm about reaffirming compliance with NASDAQ standards, highlighting that this achievement validates their strategic direction within the immuno-oncology arena. Furthermore, they emphasized the team’s dedication to advancing therapies that can improve patient care and clinical outcomes.

As Portage continues to advance its research initiatives, stakeholders can anticipate further updates detailing the company’s progress and future developments. Portage Biotech remains committed to transforming cancer treatment paradigms and enhancing the quality of life for patients across the globe.

Related news for (PRTG)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.